Pfizer Inc risk profile
53 Elevated one input has moved against it
Measured 21 October 2026 from PFE's filed statements. Recomputed nightly.
53 (Elevated), driven by Competitive position at 69, over 7 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 14 | Contained | Stable | One-year price volatility — 21.4% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 23 | Normal | Stable | Capital spending against operating cash — 0.22x |
| Leverage and coverage | 50 | Elevated | Stable | Net debt to EBITDA — 3.79x |
| Competitive position | 69 | Stretched | Stable | Revenue-growth gap against peers — -47.0 percentage points |
| Concentration | 60 | Stretched | Stable | Supplier concentration — 10,000 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.